logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Pfizer Tops Estimates in Second Quarter, Reiterates Full Year Outlook

By  +Follow July 30, 2013 8:52AM
Share:
Tickers Mentioned:

Pfizer Inc. (PFE) , the biggest drugmaker in the world, on Tuesday reported second-quarter earnings that nipped past analyst predictions as the company fought through declining sales that were hamstringed by the loss of exclusivity on the blockbuster cholesterol fighter Lipitor.

For the quarter, NYC-based Pfizer said it generated $12.97 billion in revenue, compared to $13.97 billion in the second quarter last year.  Net income soared to $14.1 billion, or $1.98 per share, versus $3.25 billion, or 43 cents per share, in last year’s quarter.  In February, Pfizer spun-out its animal health business into a new company called Zoetis, Inc. (ZTS) .  In December 2012, it sold its nutrition business to Nestle SA ($NSRGY) for $11.85 billion, accounting for most of the surge in reported income.  Excluding gains from the sale, restructuring costs and other special items, adjusted profits for the second quarter totaled $4.0 billion, or 56 cents per share, compared to $4.45 billion, or 59 cents per share, in the year prior quarter.

Wall Street was expecting EPS of 55 cents on revenue of $13.01 billion.

Sales of Lipitor sank 55 percent from $1.22 billion in the second quarter of 2012 to $545 million in the latest quarter.  Sales of pneumococcal vaccine Prevnar slipped 3 percent to $969 million due to changes in government purchasing patterns.  Counterbalancing those losses, sales of Pfizer’s biggest drug Lyrica, which is indicated for fibromyalgia, diabetic nerve pain and more, improved by 10 percent to $1.13 billion.

Revenue for Pfizer’s leading business units – primary care, specialty care, emerging markets and established products – all declined compared to the year prior quarter.  Ian Read, chairman and chief executive at Pfizer, said in today’s statement that he expects emerging market business growth to accelerate in the second of the year, led by China.

“From a total company view, we are tracking to our expectations for the full year and continue to capitalize on the investments we are making to better position Pfizer for long-term success,” added Read.

The company backed its 2013 forecast of adjusted earnings in the range of $2.10 to $2.20 per share.

Sales of anti-cancer drugs rose 24 percent to $399 million, boosted in part by a 191-percent climb in sales of Xalkori to $67 million and $17 million in sales from new drug Inlyta.

Operating margin improved significantly from 29.9 percent to 41.3 percent.

Marking “the next step in Pfizer’s journey to further revitalize [its] innovative core,” Pfizer said on Monday that it intends to split its company into three new units.  One unit will focus on drugs that are patent-protected beyond 2015.  The second will include vaccines, oncology and consumer healthcare products.  The third will include drugs that have lost – or will soon lose – patent exclusivity, generics and future product collaborations.  The changes are slated to start happening in January.

Two new drugs, blood thinner Eliquis and rheumatoid arthritis drug Xeljanz, are thought by many to have the capabilities to grow into blockbusters, although Zeljanz is facing some hurdles in Europe with negative opinions being offered by a European Medicines Agency committee.  Zeljanz generated $33 million in sales in the second quarter. The FDA is reviewing a supplemental New Drug Application (NDA) for Zeljanz with a decision expected by February.  Topline results are expected from two ongoing phase 3 trials evaluating Zeljanz in the second quarter next year.  The FDA is also reviewing a supplemental NDA for Eliquis, with a decision expected by March 15, 2014. 

During the second quarter, Pfizer repurchased $3.3 billion worth of its common stock, bringing its first-half total to $8.7 billion.

Shares of PFE have risen 20 percent so far in 2013 through Monday’s close at $29.54.  

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for PFE
Inelegant Investor
3 Jul 15 08:13:04
Summer Of Spin: Forbes' Antoine Gara Likes PayPal and Baxalta http://t.co/OEPl4mtEJI $BXLT $EBAY $ABBV $ZTS $PFE $ABT
wsnewspublishers
3 Jul 15 08:09:05
Active Stock’s Buzzers: http://t.co/N16yUJnMKb $PFE $OAS $PCG
nicholas
3 Jul 15 07:07:20
am_alerts: $PFE active, relative volume: 3.44, 1H, 10:00 AM, #nasdaq $SPY $DJIhttp://binaryoptionsocial.com
Alpha Maven Alerts
3 Jul 15 06:59:47
$PFE active, relative volume: 3.44, 1H, 10:00 AM, #nasdaq $SPY $DJI
IH News Desk
3 Jul 15 06:49:09
VRX iPath S&P 500 VIX Short-Term Futures ETN Open http://t.co/Sf3D4LMj0a $VRX $RSP $PFE $UUP #VRX #tradeideas #pennystocks
jim50
3 Jul 15 06:48:12
RSX St. Augustine Gold and Copper Ltd. Prev Close http://t.co/9yI6SkTOJc $RSX $PFE $ATH.TO $EEM #RSX #stock #stock
leahanne
3 Jul 15 06:47:06
RYE St. Augustine Gold and Copper Ltd. Ex-Div Date http://t.co/0VqEQ7jBOW $RYE $PFE $LNR.TO $HGU.TO #RYE #share #invest
PolgarStocks
3 Jul 15 06:47:03
PFE Potash Corp. of Saskatchewan, Inc. Summary http://t.co/r6NtiQ0sQ3 $PFE $CVX $ORLY $UUP #PFE #invest #tradeideas
Investors Hangout
3 Jul 15 06:45:36
PFE PowerShares Dynamic Pharmaceuticals Portfolio Filings http://t.co/CNZtwVNuBL $PFE $AEM.TO $SLB $ERD.TO #PFE #pennystocks…
lookn4wins
3 Jul 15 06:45:35
PFE PowerShares Dynamic Pharmaceuticals Portfolio Change http://t.co/LoxhvKjI8W $PFE $KBE $CTIX $JNK #PFE #stocks #tradeideas
Emylers
3 Jul 15 06:45:14
PFE ProMetic Life Sciences, Inc. Volume http://t.co/SUUyRV8NIz $PFE $NUGT $IBB $TNA #PFE #tradeideas #finance
danrocks
3 Jul 15 06:45:11
MMM.TO MannKind Corp. Ask Size http://t.co/TEgZH30lse $MMM.TO $CAT $PFE $TLT #MMM.TO #tradeideas #share
Rosner Stocks
3 Jul 15 06:44:06
MBLY McDonalds Corp. Prev Close http://t.co/KF6ve0ns72 $MBLY $ERX $IMSC $PFE #MBLY #nasdaq #investing
ProVesting
3 Jul 15 06:44:03
$PFE: Stocks With Perfect Match- Pfizer Inc. (NYSE:PFE), Baxter ...: http://t.co/C3EckP1RxY
Emylers
3 Jul 15 06:43:40
MMM.TO MannKind Corp. Yield http://t.co/LsLNYsCEIo $MMM.TO $WBA $ITB $PFE #MMM.TO #stockmarket #stocks
Rosner Stocks
3 Jul 15 06:43:36
NEM Netflix, Inc. Prev Close http://t.co/xZ4M5N6nLa $NEM $PFE $MNKD $JNJ #NEM #stock #pennystocks
Stock Forums
3 Jul 15 06:42:17
MCD Medtronic, Inc. Bid http://t.co/I5dVh9Hcwz $MCD $PFE $HND.TO $HZNP #MCD #stock #stock
danrocks
3 Jul 15 06:40:03
HSD.TO Humana, Inc. Volume http://t.co/iX96rvFEHk $HSD.TO $ERD.TO $PFE $F #HSD.TO #finance #share
DennyT
3 Jul 15 06:39:33
HOU.TO HSBC Holdings PLC P/E Ratio http://t.co/v25p7uj0jr $HOU.TO $HD $PFE $ERD.TO #HOU.TO #stocks #stockmarket
IH NASDAQ OMX
3 Jul 15 06:36:34
FB Freeport-McMoRan, Inc. Filings http://t.co/oUTaZ9QEI1 $FB $PFE $SH $MS #FB #finance #stocks
Rosner Stocks
3 Jul 15 06:36:11
EMA.TO Eastman Chemical Co. Dividend http://t.co/jbtWhMKavB $EMA.TO $FXI $PFE $GLD #EMA.TO #stock #share
IH NASDAQ OMX
3 Jul 15 06:36:06
DUST Wisdom Tree Japan Hedged Equity Dividend http://t.co/H4nt1mL9BB $DUST $XAU.V $LIF.TO $PFE #DUST #share #investing
Stock Forums
3 Jul 15 06:35:05
DD SPDR DJ Industrial Average ETF Trust Change http://t.co/xEuSuYOPeT $DD $PFE $CEU.TO $HED.TO #DD #finance #stockmarket
Rosner Stocks
3 Jul 15 06:35:03
CVE.TO Chevron Corp. Open http://t.co/JvtMUJxD2g $CVE.TO $LUN.TO $PFE $XOOM #CVE.TO #share #invest
IH NASDAQ OMX
3 Jul 15 06:34:35
CPG.TO Cellceutix Corp. Day Low http://t.co/uI3OB9xz3m $CPG.TO $PFE $DIA $AEM.TO #CPG.TO #tradeideas #investing
Rosana Kapeller
3 Jul 15 06:34:30
RT @PDRennert: Obesity rates & NASH climbing steadily http://t.co/iboCauUO6x 20+ drugs in development #simtuzumab #BMS-986036 etc $GILD $IC…
PolgarStocks
3 Jul 15 06:33:20
BND BP Amoco PLC Bid Size http://t.co/SLKx1vH2NX $BND $BAM/A.TO $QLD $PFE #BND #tradeideas #tradeideas
Lucky Jimmy
3 Jul 15 06:32:11
AMZN Africa Oil Corp. Message Board Posts http://t.co/f0oVDIX8QT $AMZN $BAC $SAU.TO $PFE #AMZN #pennystocks #share
Emylers
3 Jul 15 06:32:09
AOIFF Apricus Biosciences, Inc. Prev Close http://t.co/pO4PBApT7a $AOIFF $PFE $PBR $SLW #AOIFF #invest #stocks
danrocks
3 Jul 15 06:32:09
AMZN Africa Oil Corp. Exchange http://t.co/YdnOOelR0t $AMZN $PFE $LLY $CTIX #AMZN #finance #stocks
Investors Hangout
3 Jul 15 06:31:40
AGN AKSteel Holding Corp. Ask Size http://t.co/nXBZOgdosA $AGN $HOD.TO $VGTL $PFE #AGN #stocks #stockmarket
Ponty
3 Jul 15 06:24:17
@actaestfabulaXX @PaulGathua $PFE just jettisoned their ion-channel as Icagen 2days ago. So GL w $XENE
Stock Market Picks
3 Jul 15 06:00:18
$KO $MCD $MMM $MRK $MSFT $NKE $PFE Long and short positions from the Dow Jones, up to 1800% since 2008. http://t.co/sjQjlxfmsp $DJIA $DIA
PharmaCompass
3 Jul 15 05:15:03
Is the stop smoking app which will finally help available from Pfizer @QuittersCircle http://t.co/SqdriFtefv … $pfe #DigPharm
V.S. Schulz
3 Jul 15 05:05:53
RT @PDRennert: Obesity rates & NASH climbing steadily http://t.co/iboCauUO6x 20+ drugs in development #simtuzumab #BMS-986036 etc $GILD $IC…
Mark Punyanitya
3 Jul 15 05:00:34
RT @PDRennert: Obesity rates & NASH climbing steadily http://t.co/iboCauUO6x 20+ drugs in development #simtuzumab #BMS-986036 etc $GILD $IC…
Stock Forums
3 Jul 15 04:46:36
UVXY VelocityShares 3x Long Crude ETN Message Board Posts http://t.co/gaPT1JVRYN $UVXY $PFE $QLD $TCS #UVXY #share #finance
Jeb Keiper
3 Jul 15 04:45:42
RT @PDRennert: Obesity rates & NASH climbing steadily http://t.co/iboCauUO6x 20+ drugs in development #simtuzumab #BMS-986036 etc $GILD $IC…
Robert Stanislaro
3 Jul 15 04:45:09
RT @PDRennert: Obesity rates & NASH climbing steadily http://t.co/iboCauUO6x 20+ drugs in development #simtuzumab #BMS-986036 etc $GILD $IC…
IH News Desk
3 Jul 15 04:43:03
PFE Procter & Gamble Co. News http://t.co/wcJaDzy5HO $PFE $DIA $GDX $NCZ #PFE #tradeideas #nasdaq
binaryoptionsocial
3 Jul 15 04:42:50
MMTM Altria Group Inc. % Change http://t.co/NTvJ9RxBk2 $MMTM $ABX.TO $PFE $IBM #MMTM #nasdaq #finance http://t.co/Csk7miZSkI
Lucky Jimmy
3 Jul 15 04:42:04
MMTM Altria Group Inc. % Change http://t.co/RQaHORb5E3 $MMTM $ABX.TO $PFE $IBM #MMTM #nasdaq #finance
SwingTradeBot
3 Jul 15 04:36:12
$PFE technical alerts: Expansion Pivot Sell Setup, Bollinger Band Squeeze, Bearish Engulfing, Wide ... http://t.co/5vChcYGAL6
Kristina Duering
3 Jul 15 04:27:38
RT @PDRennert: Obesity rates & NASH climbing steadily http://t.co/iboCauUO6x 20+ drugs in development #simtuzumab #BMS-986036 etc $GILD $IC…
Thierry Alquier
3 Jul 15 04:24:34
RT @PDRennert: Obesity rates & NASH climbing steadily http://t.co/iboCauUO6x 20+ drugs in development #simtuzumab #BMS-986036 etc $GILD $IC…
Jim Johnson, Ph.D.
3 Jul 15 04:15:19
RT @PDRennert: Obesity rates & NASH climbing steadily http://t.co/iboCauUO6x 20+ drugs in development #simtuzumab #BMS-986036 etc $GILD $IC…
Bruce Booth
3 Jul 15 04:10:19
RT @PDRennert: Obesity rates & NASH climbing steadily http://t.co/iboCauUO6x 20+ drugs in development #simtuzumab #BMS-986036 etc $GILD $IC…
biotech 2050
3 Jul 15 04:05:06
RT @PDRennert: Obesity rates & NASH climbing steadily http://t.co/iboCauUO6x 20+ drugs in development #simtuzumab #BMS-986036 etc $GILD $IC…
Paul D. Rennert
3 Jul 15 04:00:35
Obesity rates & NASH climbing steadily http://t.co/iboCauUO6x 20+ drugs in development #simtuzumab #BMS-986036 etc $GILD $ICPT $PFE $GSK etc
Large Void Bot
3 Jul 15 04:00:28
Popular: $HUM, $CVX, $AET, $BB.CA, $ED, $LNKD, $X, $GBB, $SDS, $HTZ, $WFT, $VALE, $PFE, $PG, $ATVI, $T, $FXI, $LVS, $CI, $TOT, $IVV
				
				
By  +Follow July 30, 2013 8:52AM
Share:

Comments

 

blog comments powered by Disqus

 

 Today's Must Reads

Microsegmentation: The Future of Cybersecurity?


How this Playboy Playmate Became a Better Stock Trader Than You

Long Term Rates Are On The Up…What’s Next?

The Modern Web: So Many Ways to Invest in Wireless Mobile Stocks

It's Time for the Rest of the Country to Legalize Weed

 

Do you expect a 10% correction by the end of 2015? in Equities.com Polls on LockerDome

About us

Equities.com is an advanced financial data portal and social network designed to connect self-directed investors with the world’s most innovative startup and small cap companies. Through our in-depth coverage of small cap markets, comprehensive research and stock valuation reports, state of the art issuer products, and world class events, Equities.com provides the social tools and insight that drive tomorrow’s investment relationships and opportunities.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.

Login or Register

LOG IN